BGI Genomics Co., Ltd. Stock price

Equities

300676

CNE100003449

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. 07:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
40.93 CNY -0.58% Intraday chart for BGI Genomics Co., Ltd. -8.96% -14.73%
Sales 2021 6.77B 937M Sales 2022 7.05B 975M Capitalization 21.19B 2.93B
Net income 2021 1.46B 202M Net income 2022 803M 111M EV / Sales 2021 4.17 x
Net cash position 2021 7.8B 1.08B Net cash position 2022 6.21B 860M EV / Sales 2022 2.13 x
P/E ratio 2021
24.7 x
P/E ratio 2022
26.4 x
Employees -
Yield 2021
0.4%
Yield 2022
1.93%
Free-Float 52.17%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.56%
1 week-8.43%
Current month-6.90%
1 month-6.47%
3 months-13.51%
6 months-21.08%
Current year-14.23%
More quotes
1 week
40.85
Extreme 40.85
43.90
1 month
40.85
Extreme 40.85
46.76
Current year
33.00
Extreme 33
48.30
1 year
33.00
Extreme 33
79.60
3 years
33.00
Extreme 33
136.78
5 years
33.00
Extreme 33
199.40
10 years
16.37
Extreme 16.37
261.99
More quotes
Managers TitleAgeSince
Chief Executive Officer - 21-06-15
Founder 70 -
Director of Finance/CFO 46 21-06-15
Members of the board TitleAgeSince
Founder 70 -
Director/Board Member 46 -
Director/Board Member - 16-03-28
More insiders
Date Price Change Volume
24-03-28 40.93 -0.58% 2 383 900
24-03-28 41.17 +0.56% 1,962,470
24-03-27 40.94 -2.57% 2,340,765
24-03-26 42.02 -0.40% 2,691,164
24-03-25 42.19 -3.34% 3,630,472

End-of-day quote Shenzhen S.E., March 27, 2024

More quotes
BGI Genomics Co., Ltd. is a leading provider of genomic and proteomic sequencing services primarily to academic institutions, pharmaceutical companies and healthcare providers. The company also provides genomic solutions for biomarker research and development, screening for some of the trisomies present at birth (trisomy 21, trisomy 18 and trisomy 13) and solutions for neo-antigen identification for immuno-oncology research.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock BGI Genomics Co., Ltd. - Shenzhen S.E.